← FDA DRUG APPROVALS

FDA ANDA · ANDA061806

CLOXAPEN

Sponsor: GLAXOSMITHKLINE

APPLICATION
ANDA061806
TYPE
ANDA
ORIGINAL APPROVAL
1974-09-17
LATEST ACTION
1974-09-17
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

CLOXAPENDiscontinued
CLOXACILLIN SODIUM EQ 500MG BASE · CAPSULE · ORAL
CLOXAPENDiscontinued
CLOXACILLIN SODIUM EQ 250MG BASE · CAPSULE · ORAL

Approval history

1974-09-17OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →